Company page

Zymeworks Inc.

Zymeworks Inc. is a public biotechnology company listed under the ticker ZYME, operating in the American market. The company focuses on developing innovative therapeutics for cancer and other serious diseases. With a market capitalization of approximately $1.7 billion, Zymeworks is dedicated to advancing its proprietary technology platforms to improve patient outcomes.